pentobarbital and daridorexant both enhance sedation. Modify Therapy/Keep an eye on Closely. Coadministration increases hazard of CNS despair, which may result in additive impairment of psychomotor effectiveness and lead to daytime impairment.pentobarbital will decrease the level or result of mestranol by affecting hepatic/intestinal enzyme CYP3A4